A multi-omics based anti-inflammatory immune signature characterizes Long COVID Syndrome - Kovarik et al.

Published: 18 November 2022| Version 1 | DOI: 10.17632/sv8hx7gkxp.1
Contributor:
Christopher Gerner

Description

Supplementary Table S1 related to Figure 1: Student's t-test statistics between long-covid and recovered, long-covid and healthy as well as recovered and healthy are shown. For each identified protein, log2 label-free quantification (LFQ) intensities, numbers of identified peptides, numbers of identified unique peptides as well as the sequence coverage is listed. Supplementary Table S2 related to Figure 2: Student's t-test statistics between long-covid and recovered, long-covid and healthy as well as recovered and healthy are shown. For each identified eicosanoid normalized area under the curve (nAUC) values are listed. Supplementary Table S3 related to Figure 3: Student's t-test statistics between long-covid and recovered, long-covid and healthy as well as recovered and healthy are shown. For each identified metabolite log2 concentrations in µM are listed. Supplementary Table S4 related to Figure 3: Heatmap data matrix. Normalized values generated by dividing the concentration of each lipid through the average concentration of this lipid over all samples.

Files

Institutions

Universitat Wien Massenspektrometriezentrum

Categories

Proteomics, Metabolomics, Eicosanoids

Funding

Austrian Science Fund

P-34728B

Licence